Adicet Bio (ACET) Gains from Investment Securities (2019 - 2021)
Adicet Bio (ACET) posted quarterly Gains from Investment Securities of -$600000.0 for Q2 2021, down 4715.38% year-over-year from $13000.0 in Q2 2020, and down 57.89% quarter-over-quarter from -$380000.0 in Q1 2021.
Adicet Bio (ACET) Gains from Investment Securities (2019 - 2021) Analysis & Trends
Adicet Bio's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$600000.0 for Q2 2021.
- In Q2 2021, Gains from Investment Securities fell 4715.38% year-over-year to -$600000.0; the TTM figure through Mar 2022 stood at -$600000.0 (down 202.21% YoY), while the FY2021 annual figure was -$980000.0, down 209.25% from the prior year.
- Gains from Investment Securities for Q2 2021 stood at -$600000.0, down from -$380000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $954000.0 in Q3 2020, with the low at -$600000.0 in Q2 2021.
- The 3-year median for Gains from Investment Securities is -$70000.0 (2020), against an average of -$24428.6.
- The sharpest annual moves came in 2020 and 2021: Gains from Investment Securities jumped 854.0% in 2020, then tumbled 4715.38% in 2021.
- Adicet Bio's Gains from Investment Securities stood at -$188000.0 in 2019, then surged by 607.45% to $954000.0 in 2020, then plunged by 162.89% to -$600000.0 in 2021.
- Business Quant data shows ACET's Gains from Investment Securities at -$600000.0 in Q2 2021, -$380000.0 in Q1 2021, and $954000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -600,000.00 |
| Jun 30, 2021 | -600,000.00 |
| Mar 31, 2021 | -380,000.00 |
| Mar 31, 2021 | -380,000.00 |
| Sep 30, 2020 | 954,000.00 |
| Sep 30, 2020 | 954,000.00 |
| Jun 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 13,000.00 |
| Mar 31, 2020 | -70,000.00 |
| Mar 31, 2020 | -70,000.00 |
| Dec 31, 2019 | -188,000.00 |
| Dec 31, 2019 | -188,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |